Iris claw lens insertion useful in aphakic patients

Article

A recent investigation included in Eye has found that performing Artisan iris claw lens insertion is beneficial in acquired aphakia.

A recent investigation included in Eye has found that performing Artisan iris claw lens insertion is beneficial in acquired aphakia.

The study, led by Dr K.S. Lett, Department of Ophthalmology, University Hospitals of Leicester, Leicester, UK, involved a retrospective analysis of 32 aphakic eyes of 31 patients that had experienced Artisan lens implantation. The follow-up varied between 6 and 42 months, with a mean of 17.3 months. Complicated phacoemulsification was the most common cause of aphakia with 17 of the 32 eyes presenting with it.

Best-corrected visual acuity (BCVA) that exceeded preoperative data was gained in 21 of the 32 eyes included in the evaluation. Preoperative BCVA was matched postoperatively in 10 eyes and one eye presented with a BCVA worse than the preoperative data. This was due to non-arteritic anterior ischaemic, optic neuropathy.

Pre-existing glaucoma or ocular hypertension was found in 4 of the total study eyes. There were no problems with intraocular pressure, uveitis, glaucoma or hyphaema during the follow-up period.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.